Abstract
Galanthus nivalis agglutinin (GNA)-related lectin family, a superfamily of strictly mannose-binding specific lectins widespread among monotyledonous plants, is well-known to possess a broad range of biological functions such as anti-tumor, anti-fungal and anti-viral activities. Growing insights into the investigations of them provide us a principal force to start this review with a variety of evidences to landmark their biological activities, molecular mechanisms and potential therapeutic applications. Herein, we mainly focused on a comprehensive study on a great number of reported GNA-related lectins with the anti-tumor activity. On the trail of such clues, we studied some GNA-related lectins with anti-tumor effects and explored the apoptosis- and autophagy-induced activities and related molecular mechanisms. These inspiring results further provide us more convincing evidence to understand the anti-cancer molecular mechanisms implicated in apoptosis and autophagy. In addition, GNA-related lectins also possess marked anti-HIV activities and the specific molecular mechanisms are also explored herein. To sum up, GNA-related lectin family would play a key role as a potential drug in future therapeutics.
Keywords: GNA-related lectins, anti-tumor activity, apoptosis, autophagy, drug
Current Chemical Biology
Title: Galanthus nivalis Agglutinin (GNA)-Related Lectins: Traditional Proteins, Burgeoning Drugs?
Volume: 3 Issue: 3
Author(s): Chun-yang Li, Liang Meng, Bo Liu and Jin-ku Bao
Affiliation:
Keywords: GNA-related lectins, anti-tumor activity, apoptosis, autophagy, drug
Abstract: Galanthus nivalis agglutinin (GNA)-related lectin family, a superfamily of strictly mannose-binding specific lectins widespread among monotyledonous plants, is well-known to possess a broad range of biological functions such as anti-tumor, anti-fungal and anti-viral activities. Growing insights into the investigations of them provide us a principal force to start this review with a variety of evidences to landmark their biological activities, molecular mechanisms and potential therapeutic applications. Herein, we mainly focused on a comprehensive study on a great number of reported GNA-related lectins with the anti-tumor activity. On the trail of such clues, we studied some GNA-related lectins with anti-tumor effects and explored the apoptosis- and autophagy-induced activities and related molecular mechanisms. These inspiring results further provide us more convincing evidence to understand the anti-cancer molecular mechanisms implicated in apoptosis and autophagy. In addition, GNA-related lectins also possess marked anti-HIV activities and the specific molecular mechanisms are also explored herein. To sum up, GNA-related lectin family would play a key role as a potential drug in future therapeutics.
Export Options
About this article
Cite this article as:
Li Chun-yang, Meng Liang, Liu Bo and Bao Jin-ku, Galanthus nivalis Agglutinin (GNA)-Related Lectins: Traditional Proteins, Burgeoning Drugs?, Current Chemical Biology 2009; 3 (3) . https://dx.doi.org/10.2174/2212796810903030324
DOI https://dx.doi.org/10.2174/2212796810903030324 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardio-Protective Effects of Sodium-Glucose Co-Transporter 2 Inhibitors: Focus on Heart Failure
Current Pharmaceutical Design The Antidiabetic Therapeutic Potential of Dietary Polyphenols
Current Pharmaceutical Biotechnology Telomeres, Senescence and Longevity: The Role of Oxidative Stress and Antioxidants
Current Pharmacogenomics A Review on Hematopoietic Stem Cell Treatment for Epilepsy
CNS & Neurological Disorders - Drug Targets Preclinical Development of New Therapy for Glycogen Storage Diseases
Current Gene Therapy Cardiac Metabolism in Diabetes Mellitus
Current Pharmaceutical Design Dietary Antioxidants: Immunity and Host Defense
Current Topics in Medicinal Chemistry Cystatin C: An Emerging Biomarker in Cardiovascular Disease
Current Topics in Medicinal Chemistry Free Radicals in Diseases and Potential Role of Phytoconstituents-A Cause with Emerging Importance
Current Chemical Biology Taurine-Diabetes Interaction: From Involvement to Protection
Current Diabetes Reviews The Role of Calcium and the L-Type Calcium Channel in Pathological Remodeling of the Heart
Vascular Disease Prevention (Discontinued) Endothelial Cell Senescence and Inflammaging: MicroRNAs as Biomarkers and Innovative Therapeutic Tools
Current Drug Targets Impact of RET Screening on the Management of Multiple Endocrine Neoplasia Type 2A: 10 Years Experience and Follow-Up in Three Families
Endocrine, Metabolic & Immune Disorders - Drug Targets Peripartum Cardiomyopathy: Moving Towards a More Central Role of Genetics
Current Cardiology Reviews Lost in Translation: What is Limiting Cardiomyoplasty and Can Tissue Engineering Help?
Current Stem Cell Research & Therapy Cardiovascular Disease in Antiphospholipid Syndrome
Current Vascular Pharmacology Inflammatory Biomarkers and Therapeutic Targets in Heart Failure
Current Medicinal Chemistry Sex Differences in Biomarkers for Predicting Cardiovascular and Coronary Events
Current Vascular Pharmacology Expression and Functions of Heat Shock Proteins in the Normal and Pathological Mammalian Eye
Current Molecular Medicine Self Managing Heart Failure in Remote Australia - Translating Concepts into Clinical Practice
Current Cardiology Reviews